GALMED PHARMACEUTICALS LTD. Debt Securities, Available-for-sale, Gain (Loss)
GALMED PHARMACEUTICALS LTD. (GLMD) reported Debt Securities, Available-for-sale, Gain (Loss) of $81.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleGainLoss · last filed 2026-03-31
| Period end | Debt Securities, Available-for-sale, Gain (Loss) 12 month | Debt Securities, Available-for-sale, Gain (Loss) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $81.00K 20-F · filed 2026-03-31 | |
| 2024-12-31 | $12.00K 20-F · filed 2026-03-31 | |
| 2023-12-31 | $13.00K 20-F · filed 2026-03-31 | |
| 2022-12-31 | $526.00K 20-F · filed 2025-04-02 | |
| 2021-12-31 | $80.00K 20-F · filed 2024-04-04 | |
| 2020-12-31 | -$397.00K 20-F · filed 2023-03-29 | $397.00K 20-F · filed 2021-03-18 |
| 2019-12-31 | -$106.00K 20-F · filed 2022-05-02 | $106.00K 20-F · filed 2020-03-12 |
| 2018-12-31 | $12.00K 20-F · filed 2021-03-18 | |
| 2017-12-31 | -$182.00K 20-F · filed 2020-03-12 | |
| 2016-12-31 | -$305.00K 20-F · filed 2019-03-13 |